- John Lee, 79, Elizabethtown, KY (1942-2022)
- Attleboro, Mansfield students top Bishop-Feehan senior class
- Robbie Williams’ wife Ayda Field shares a selfie from hospital as she undergoes a colonoscopy
- Takeda and Seagen to Highlight ADCETRIS® Combination Data Showing Statistically Significant Improvement in Overall Survival (OS) for Patients with Advanced Hodgkin Lymphoma
- Surging Chronic Diseases favorable to Global Drug Discovery Market Growth
- Surging Chronic Diseases favorable to Global Drug Discovery Market Growth
- Takeda and Seagen to Highlight ADCETRIS® Combination Data Showing Statistically Significant Improvement in Overall Survival (OS) for Patients with Advanced Hodgkin Lymphoma
- Ipsen: ASCO 2022: New Cabometyx® Data Show Encouraging Results in Monotherapy and in Combination Across Different Tumor Types Including Metastatic Non-Small Cell Lung Cancer
- Lessons From the Syrian Crises for Cancer Care in Ukraine
- NEW DATA SHOWCASES HOW AMGEN IS ADVANCING ALL ANGLES OF CANCER CARE THROUGH INNOVATIVE ONCOLOGY PORTFOLIO AND PIPELINE AT ASCO 2022
- Surging Chronic Diseases favorable to Global Drug Discovery Market Growth
- EQRx Announces New Data for Lead Oncology Programs in Non-small Cell Lung Cancer and Rare Form of Non-Hodgkin Lymphoma at ASCO 2022
- 23andMe Reports FY2022 Fourth Quarter and Full Year Financial Results
- CARVYKTI® (Ciltacabtagene Autoleucel) erhält von der Europäischen Kommission bedingte Zulassung für die Behandlung von Patienten mit rezidiviertem und refraktärem multiplem Myelom
- CARVYKTI® (Ciltacabtagene Autoleucel) erhält von der Europäischen Kommission bedingte Zulassung für die Behandlung von Patienten mit rezidiviertem und refraktärem multiplem Myelom